Here, we demonstrate that BATF3-deficiency leads to the development of metabolic syndrome as characterized by insulin resistance, blood glucose and serum insulin levels, increased body weight and white adipocyte size, and development of hepatosteatosis. This evidence concerns the gene INS and Insulin resistance.